Breaking Nigeria Kicks Off Presidential Campaigns Amidst Economic and Security Challenges Unitree’s Stock Soars 629% on Shanghai Debut, Raising $904 Million First US Jellyfish Museum Opens in Pompano Beach, Florida Ukraine Targets Logistics Hub Near Moscow with Drone Attack Brewers Tie Modern-Era Record with Dominant 22-0 Shutout Victory Over Mariners

Wednesday August 19, 2026

Reporter

Radiopharm Theranostics

5Articles Published

5Communities Covered

Published Articles

Press Release

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

16 hours ago

Press Release

Radiopharm Theranostics Reports Business Update

Jul 31

Press Release

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Jul 24

Press Release

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Jul 22

Press Release

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Jul 22